Allergy Immunotherapies Market Scope and Analysis Report by 2031
Allergy Immunotherapies Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 2.16 Billion |
Market Size by 2031 | US$ 5.11 Billion |
Global CAGR (2023 - 2031) | 9.0% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Treatment
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Allergy Immunotherapies Market News and Recent Developments
The allergy immunotherapies market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for allergy immunotherapies and strategies:
- In August 2020, Nestlé Health Science acquired Aimmune Therapeutics. Aimmune's approved therapy Palforzia would expand Nestlé Health Science portfolio with first and only FDA-approved treatment to help reduce the frequency and severity of allergic reactions to peanuts in children. (Source: Company Press Release)
- In September 2023, Stallergenes Greer entered into an agreement with Nestlé Health Science to harness the peanut allergy oral immunotherapy treatment Palforzia. (Source: Company Press Release)
Allergy Immunotherapies Market Report Coverage and Deliverables
The “Allergy Immunotherapies Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles